CA2932983C - Web-based computer-aided method and a system for providing personalized recommendations about drug use, and a computer-readable medium - Google Patents

Web-based computer-aided method and a system for providing personalized recommendations about drug use, and a computer-readable medium Download PDF

Info

Publication number
CA2932983C
CA2932983C CA2932983A CA2932983A CA2932983C CA 2932983 C CA2932983 C CA 2932983C CA 2932983 A CA2932983 A CA 2932983A CA 2932983 A CA2932983 A CA 2932983A CA 2932983 C CA2932983 C CA 2932983C
Authority
CA
Canada
Prior art keywords
information
drug
personalized
genetic
personalized recommendations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA2932983A
Other languages
English (en)
French (fr)
Other versions
CA2932983A1 (en
Inventor
Jordi PRATSEVALL GARCIA
David REDONDO AMADO
Miquel TUSON SEGARRA
Silvia VILCHES SAEZ
Jordi Espadaler Mazo
Ariana SALAVERT LARROSA
Miquel Angel Bonachera Sierra
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Precision Molecular Solutions LLC
Original Assignee
AB Biotics SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AB Biotics SA filed Critical AB Biotics SA
Publication of CA2932983A1 publication Critical patent/CA2932983A1/en
Application granted granted Critical
Publication of CA2932983C publication Critical patent/CA2932983C/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16C—COMPUTATIONAL CHEMISTRY; CHEMOINFORMATICS; COMPUTATIONAL MATERIALS SCIENCE
    • G16C20/00—Chemoinformatics, i.e. ICT specially adapted for the handling of physicochemical or structural data of chemical particles, elements, compounds or mixtures
    • G16C20/30—Prediction of properties of chemical compounds, compositions or mixtures
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/48—Other medical applications
    • A61B5/4836—Diagnosis combined with treatment in closed-loop systems or methods
    • A61B5/4839—Diagnosis combined with treatment in closed-loop systems or methods combined with drug delivery
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G16B20/20—Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16C—COMPUTATIONAL CHEMISTRY; CHEMOINFORMATICS; COMPUTATIONAL MATERIALS SCIENCE
    • G16C20/00—Chemoinformatics, i.e. ICT specially adapted for the handling of physicochemical or structural data of chemical particles, elements, compounds or mixtures
    • G16C20/10—Analysis or design of chemical reactions, syntheses or processes
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16C—COMPUTATIONAL CHEMISTRY; CHEMOINFORMATICS; COMPUTATIONAL MATERIALS SCIENCE
    • G16C20/00—Chemoinformatics, i.e. ICT specially adapted for the handling of physicochemical or structural data of chemical particles, elements, compounds or mixtures
    • G16C20/90—Programming languages; Computing architectures; Database systems; Data warehousing
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/60—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H70/00—ICT specially adapted for the handling or processing of medical references
    • G16H70/40—ICT specially adapted for the handling or processing of medical references relating to drugs, e.g. their side effects or intended usage
    • H—ELECTRICITY
    • H04—ELECTRIC COMMUNICATION TECHNIQUE
    • H04L—TRANSMISSION OF DIGITAL INFORMATION, e.g. TELEGRAPHIC COMMUNICATION
    • H04L41/00—Arrangements for maintenance, administration or management of data switching networks, e.g. of packet switching networks
    • H04L41/22—Arrangements for maintenance, administration or management of data switching networks, e.g. of packet switching networks comprising specially adapted graphical user interfaces [GUI]
    • H—ELECTRICITY
    • H04—ELECTRIC COMMUNICATION TECHNIQUE
    • H04L—TRANSMISSION OF DIGITAL INFORMATION, e.g. TELEGRAPHIC COMMUNICATION
    • H04L67/00—Network arrangements or protocols for supporting network services or applications
    • H04L67/01—Protocols
    • H04L67/02—Protocols based on web technology, e.g. hypertext transfer protocol [HTTP]
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations

Landscapes

  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medical Informatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Theoretical Computer Science (AREA)
  • Public Health (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Epidemiology (AREA)
  • Primary Health Care (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Computing Systems (AREA)
  • Analytical Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Evolutionary Biology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Signal Processing (AREA)
  • Computer Networks & Wireless Communication (AREA)
  • Toxicology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pathology (AREA)
  • Human Computer Interaction (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Software Systems (AREA)
  • Databases & Information Systems (AREA)
  • Medical Treatment And Welfare Office Work (AREA)
CA2932983A 2013-12-12 2014-12-10 Web-based computer-aided method and a system for providing personalized recommendations about drug use, and a computer-readable medium Active CA2932983C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361915077P 2013-12-12 2013-12-12
US61/915,077 2013-12-12
PCT/IB2014/002715 WO2015087140A1 (en) 2013-12-12 2014-12-10 Web-based computer-aided method and system for providing personalized recommendations about drug use, and a computer-readable medium

Publications (2)

Publication Number Publication Date
CA2932983A1 CA2932983A1 (en) 2015-06-18
CA2932983C true CA2932983C (en) 2021-06-08

Family

ID=52434853

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2932983A Active CA2932983C (en) 2013-12-12 2014-12-10 Web-based computer-aided method and a system for providing personalized recommendations about drug use, and a computer-readable medium

Country Status (7)

Country Link
US (1) US10943672B2 (https=)
EP (1) EP3080738A1 (https=)
JP (1) JP6596424B2 (https=)
KR (1) KR102362422B1 (https=)
CN (1) CN105981024B (https=)
CA (1) CA2932983C (https=)
WO (1) WO2015087140A1 (https=)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3239869A1 (en) 2016-04-29 2017-11-01 Fujitsu Limited A system and method to produce and validate weighted relations between drug and adverse drug reactions
CN106326652A (zh) * 2016-08-23 2017-01-11 北京博奥医学检验所有限公司 一种肿瘤智能用药指导系统
US10621558B2 (en) 2016-10-07 2020-04-14 Bank Of America Corporation System for automatically establishing an operative communication channel to transmit instructions for canceling duplicate interactions with third party systems
US10510088B2 (en) * 2016-10-07 2019-12-17 Bank Of America Corporation Leveraging an artificial intelligence engine to generate customer-specific user experiences based on real-time analysis of customer responses to recommendations
US10476974B2 (en) 2016-10-07 2019-11-12 Bank Of America Corporation System for automatically establishing operative communication channel with third party computing systems for subscription regulation
WO2018140156A1 (en) * 2017-01-27 2018-08-02 Orig3N, Inc. Systems and methods for determining and presenting purchase recommendations based on personal genetic profiles
CN108629149B (zh) * 2017-03-21 2023-04-07 达易特基因科技股份有限公司 基因检测平台方法
CN120636518A (zh) * 2017-05-12 2025-09-12 密歇根大学董事会 个体和队列药理学表型预测平台
CN107273710A (zh) * 2017-08-22 2017-10-20 北京岙特杰诺生物科技有限公司 一种建立药物代谢酶基因与药物代谢的关系模型的方法
JP7320345B2 (ja) * 2017-10-27 2023-08-03 シスメックス株式会社 遺伝子解析方法、遺伝子解析装置、遺伝子解析システム、プログラム、および記録媒体
WO2019083024A1 (ja) * 2017-10-27 2019-05-02 シスメックス株式会社 遺伝子解析方法、遺伝子解析装置、管理サーバ、遺伝子解析システム、プログラム、および記録媒体
CA3080468A1 (en) 2017-10-30 2019-05-09 Endocanna Health, Inc. Cannabinoid formulations
CN108682458A (zh) * 2018-05-08 2018-10-19 北京岙特杰诺生物科技有限公司 用药管理方法、装置及电子设备
WO2020005321A1 (en) * 2018-06-28 2020-01-02 Powell Roberta D Patient-facing digital platform for health literacy and numeracy
US20200004928A1 (en) * 2018-06-29 2020-01-02 Roche Sequencing Solutions, Inc. Computing device with improved user interface for interpreting and visualizing data
IT201800007351A1 (it) * 2018-07-19 2020-01-19 Sistema e metodo attuato mediante calcolatore per visualizzazione dinamica d’interazione tra farmaci
WO2020091375A2 (ko) * 2018-10-29 2020-05-07 고려대학교 산학협력단 항우울제 추천 방법 및 시스템
US20220310208A1 (en) * 2019-06-13 2022-09-29 Roche Sequencing Solutions, Inc. Systems and methods with improved user interface for interpreting and visualizing longitudinal
EP3822974A1 (en) * 2019-11-15 2021-05-19 Stalicla S.A. Computational platform to identify therapeutic treatments for neurodevelopmental conditions
KR20210096402A (ko) * 2020-01-28 2021-08-05 (주)인테그로메디랩 증례 데이터 기반 천연물 추천 장치 및 방법
KR20210103338A (ko) 2020-02-13 2021-08-23 윤명철 유전자 정보를 이용하는 상품 추천 시스템 및 방법
US11238967B1 (en) * 2021-02-24 2022-02-01 Flatiron Health, Inc. Systems and methods for generating dynamic graphical user interfaces for dose recalculations and adjustments
KR102918109B1 (ko) * 2021-06-07 2026-01-28 (주) 애니펜 콘텐츠를 제공하기 위한 방법, 시스템 및 비일시성의 컴퓨터 판독 가능 기록 매체
WO2024053860A1 (ko) 2022-09-05 2024-03-14 주식회사 지놈인사이트테크놀로지 유전 정보 분석 결과 제공 방법 및 시스템
KR102834065B1 (ko) * 2022-09-22 2025-07-16 서울대학교산학협력단 약동학적 변화량 예측 장치 및 방법
CN120641989A (zh) * 2022-10-06 2025-09-12 蓝色基因实验室有限责任公司 药物相互作用分析的系统和方法
KR102659367B1 (ko) * 2023-08-04 2024-04-22 웰트 주식회사 멀티소스 데이터 분석을 기반으로 한 맞춤형 디지털 치료제 생성 방법 및 이러한 방법을 수행하는 장치
CN118737369B (zh) * 2024-06-07 2025-07-01 武汉海云健康科技股份有限公司 一种基于多任务学习的个性化用药推荐方法、设备及存储介质
CN118737311B (zh) * 2024-09-03 2024-11-22 艾伟拓(江苏)医药科技有限公司 一种二甲氨丁酸二亚油甲酯配伍方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060034508A1 (en) * 2004-06-07 2006-02-16 Zhou Xiang S Computer system and method for medical assistance with imaging and genetics information fusion
US7504227B2 (en) * 2004-10-20 2009-03-17 University Of Washington Drug targets for the treatment of neurodegenerative disorders
EP3703058A1 (en) * 2005-11-29 2020-09-02 Children's Hospital Medical Center A method of selecting a medication for a patient
US8099298B2 (en) * 2007-02-14 2012-01-17 Genelex, Inc Genetic data analysis and database tools
CN102067142A (zh) * 2008-02-26 2011-05-18 普渡研究基金会 用于患者基因分型的方法
KR20110074527A (ko) * 2008-09-12 2011-06-30 네이비제닉스 인크. 복수의 환경 및 유전 위험 인자를 통합하기 위한 방법 및 시스템
CN101429544A (zh) * 2008-12-18 2009-05-13 黄行许 利用rna干扰文库筛选肿瘤化疗药物敏感基因的方法
US20110082867A1 (en) * 2009-10-06 2011-04-07 NeX Step, Inc. System, method, and computer program product for analyzing drug interactions
US9773091B2 (en) 2011-10-31 2017-09-26 The Scripps Research Institute Systems and methods for genomic annotation and distributed variant interpretation

Also Published As

Publication number Publication date
CA2932983A1 (en) 2015-06-18
JP6596424B2 (ja) 2019-10-23
CN105981024B (zh) 2019-03-26
US10943672B2 (en) 2021-03-09
US20160314251A1 (en) 2016-10-27
EP3080738A1 (en) 2016-10-19
WO2015087140A1 (en) 2015-06-18
KR20160099618A (ko) 2016-08-22
CN105981024A (zh) 2016-09-28
JP2017503258A (ja) 2017-01-26
KR102362422B1 (ko) 2022-02-11

Similar Documents

Publication Publication Date Title
CA2932983C (en) Web-based computer-aided method and a system for providing personalized recommendations about drug use, and a computer-readable medium
Chinnasamy et al. Health recommendation system using deep learning-based collaborative filtering
Brown et al. The clinical utility of combinatorial pharmacogenomic testing for patients with depression: a meta-analysis
Dilla et al. Systematic review of the economic aspects of nonadherence to antipsychotic medication in patients with schizophrenia
Markey et al. Clinical trials are becoming more complex: a machine learning analysis of data from over 16,000 trials
Brandes et al. Can the common-sense model predict adherence in chronically ill patients? A meta-analysis
Tamblyn et al. A randomized trial of the effectiveness of on-demand versus computer-triggered drug decision support in primary care
Whalley Buono et al. Coming full circle in the measurement of medication adherence: opportunities and implications for health care
Duke et al. Adherence to drug—drug interaction alerts in high-risk patients: a trial of context-enhanced alerting
Pinem et al. Designing a health referral mobile application for high-mobility end users in Indonesia
JP2017503258A5 (https=)
Eugene et al. A pharmacodynamic modelling and simulation study identifying gender differences of daily olanzapine dose and dopamine D2-receptor occupancy
Woosley et al. Assessing cardiovascular drug safety for clinical decision-making
Lee et al. Opportunities and challenges of a dynamic consent-based application: personalized options for personal health data sharing and utilization
US20140229191A1 (en) Prescription decision support system and method using comprehensive multiplex drug monitoring
US10642445B2 (en) Methods and apparatus for processing medical data from a plurality of users
Ma et al. Big data in pharmacy practice: current use, challenges, and the future
US20210049719A1 (en) Methods and Apparatus for Processing Medical Data From A Plurality Of Users
Shoshi et al. GraphSAW: A web-based system for graphical analysis of drug interactions and side effects using pharmaceutical and molecular data
Kamath et al. Burden of death and disability due to adverse effects of medical treatment in India: An analysis using the global burden of disease 2019 study data
Rothenbacher et al. New opportunities of real-world data from clinical routine settings in life-cycle management of drugs: example of an integrative approach in multiple sclerosis
Lee et al. Development of safety and usability guideline for clinical information system
Sehgal et al. Disparities by race and urbanicity in online health care facility reviews
Roederer et al. Applying the genome to national drug formulary policy in the developing world
Nadkarni et al. Medical costs and utilization in patients with depression treated with adjunctive atypical antipsychotic therapy

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20191210

MPN Maintenance fee for patent paid

Free format text: FEE DESCRIPTION TEXT: MF (PATENT, 10TH ANNIV.) - STANDARD

Year of fee payment: 10

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20241206

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT DETERMINED COMPLIANT

Effective date: 20241206